Azioni Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Azioni
TEVA
IL0006290147
Prodotti farmaceutici
Fatturato 2024 * | 15,86 Mrd 59,63 Mrd 14,89 Mrd | Fatturato 2025 * | 16,35 Mrd 61,44 Mrd 15,34 Mrd | Capitalizzazione | 14,57 Mrd 54,75 Mrd 13,67 Mrd |
---|---|---|---|---|---|
Risultato netto 2024 * | 1,54 Mrd 5,78 Mrd 1,44 Mrd | Risultato netto 2025 * | 1,44 Mrd 5,42 Mrd 1,35 Mrd | EV/Fatturato 2024 * | 1,84 x |
Indebitamento netto 2024 * | 14,62 Mrd 54,97 Mrd 13,73 Mrd | Indebitamento netto 2025 * | 12,12 Mrd 45,55 Mrd 11,38 Mrd | EV/Fatturato 2025 * | 1,63 x |
P/E ratio 2024 * |
10,3
x | P/E ratio 2025 * |
9,61
x | Dipendenti | - |
Rendimento 2024 * |
-
| Rendimento 2025 * |
-
| Flottante | 89,71% |
Ultimo resoconto su Teva Pharmaceutical Industries Limited
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 60 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+24,60% | 654 Mrd | |
+24,08% | 552 Mrd | |
-5,63% | 356 Mrd | |
+15,37% | 319 Mrd | |
+7,38% | 295 Mrd | |
+3,26% | 211 Mrd | |
+0,78% | 206 Mrd | |
-9,69% | 147 Mrd | |
-6,63% | 144 Mrd |